United States

Relypsa Inc (RLYP)

Track

Track

Relypsa Inc experienced notable insider trading activity throughout mid-2016. The most recent transactions occurred in August 2016, featuring a mix of share acquisitions and divestments by various stakeholders. Significant selling volume was observed from institutional entities during July, while individual officers engaged in both buying and selling actions earlier that summer.
Ticker: RLYP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
DONDERO JAMES D Large shareholder
Transaction date
Purchase
Price
223.03
Quantity 63,431 -43.4%
Value US$1,074,364
Montgomery Monte Chief Accounting Officer Officer
Transaction date
Sale
Price
137.68
Quantity 67,186 -36.2%
Value US$4,827,835
DONDERO JAMES D Large shareholder
Transaction date
Sale
Price
404.67
Quantity 51,272 -28.1%
Value US$412,302
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
31.98
Quantity 343,600 -9.3%
Value US$10,988,328
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
32.00
Quantity 3,700,000 -50.0%
Value US$118,400,000
SPIEGELMAN DANIEL K Non-Executive Director
Transaction date
Sale
Price
19.31
Quantity 1,013 -45.0%
Value US$19,562
Hillan Kenneth J. Non-Executive Director
Transaction date
Sale
Price
19.31
Quantity 1,013 -45.0%
Value US$19,563
Butler John P. Non-Executive Director
Transaction date
Sale
Price
19.32
Quantity 1,013 -26.2%
Value US$19,570
Torley Helen Non-Executive Director
Transaction date
Sale
Price
19.32
Quantity 1,013 -45.0%
Value US$19,570
HASTINGS PAUL J Non-Executive Director
Transaction date
Sale
Price
19.32
Quantity 1,013 -28.9%
Value US$19,573
MCGIRR DAVID W J Non-Executive Director
Transaction date
Sale
Price
19.34
Quantity 1,013 -27.1%
Value US$19,588
BALL KRISTINE M Chief Financial Officer & SVP Officer
Transaction date
Purchase
Price
12.15
Quantity 7,000 +32.9%
Value US$85,050
Schuetz Thomas J. Non-Executive Director
Transaction date
Purchase
Price
13.39
Quantity 30,000 +757.2%
Value US$401,832
Stahl Wilhelm SVP, Chief Technology Officer Officer
Transaction date
Planned sale
Price
28.53
Quantity 20,000 -57.4%
Value US$570,558
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
27.54
Quantity 52,058 -0.7%
Value US$1,433,677
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
26.78
Quantity 47,942 -0.6%
Value US$1,283,887
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
27.02
Quantity 38,630 -0.5%
Value US$1,043,783
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
26.39
Quantity 111,370 -1.5%
Value US$2,939,054
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
28.39
Quantity 14,171 -0.2%
Value US$402,315
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
27.50
Quantity 235,829 -3.0%
Value US$6,485,298
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
29.50
Quantity 750 -3.4%
Value US$22,125
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
29.78
Quantity 30,000 -58.5%
Value US$893,400
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
29.67
Quantity 800 -1.4%
Value US$23,733
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
28.52
Quantity 7,379 -11.8%
Value US$210,451
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
27.85
Quantity 6,821 -9.8%
Value US$189,949
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 20,000 -25.2%
Value US$500,000
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 20,000 -25.2%
Value US$500,000
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
12.92
Quantity 310,700 +4.1%
Value US$4,014,244
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
11.97
Quantity 189,300 +2.6%
Value US$2,265,921
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 2,366 -5.3%
Value US$59,150
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
34.14
Quantity 200 -0.8%
Value US$6,828
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
33.51
Quantity 9,800 -28.0%
Value US$328,397
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
34.11
Quantity 200 -0.7%
Value US$6,822
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
33.57
Quantity 19,800 -39.6%
Value US$664,751
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
36.94
Quantity 5,204 -14.8%
Value US$192,255
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
35.79
Quantity 8,351 -19.2%
Value US$298,893
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
36.98
Quantity 5,306 -13.2%
Value US$196,208
Orwin John A President & CEO Executive Director
Transaction date
Planned sale
Price
36.40
Quantity 14,694 -26.7%
Value US$534,793
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
34.13
Quantity 1,457,551 -16.5%
Value US$49,746,216
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
36.06
Quantity 5,834 -68.3%
Value US$210,387
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
35.35
Quantity 5,832 -68.3%
Value US$206,179
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
38.67
Quantity 5,834 -68.3%
Value US$225,594
BALL KRISTINE M Chief Financial Officer & SVP Officer
Transaction date
Planned sale
Price
41.00
Quantity 3,000 -28.6%
Value US$123,000
Lockey Claire See Remarks Officer
Transaction date
Planned sale
Price
40.00
Quantity 10,000 -64.5%
Value US$400,000
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
39.00
Quantity 348 -6.0%
Value US$13,572
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
39.00
Quantity 5,000 -46.1%
Value US$195,000
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
38.63
Quantity 2,300 -23.5%
Value US$88,843
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
37.82
Quantity 2,700 -21.6%
Value US$102,106
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
39.00
Quantity 5,000 -24.0%
Value US$195,000
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.74
Quantity 100 -3.6%
Value US$3,274
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.10
Quantity 5,734 -67.1%
Value US$184,085
Lockey Claire See Remarks Officer
Transaction date
Planned sale
Price
35.00
Quantity 5,000 -47.6%
Value US$175,000
BALL KRISTINE M Chief Financial Officer & SVP Officer
Transaction date
Planned sale
Price
36.00
Quantity 3,000 -28.6%
Value US$108,000
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
35.00
Quantity 55,000 -68.0%
Value US$1,925,000
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
34.09
Quantity 1,080 -4.0%
Value US$36,821
Krasnow Ronald A. See Remarks Officer
Transaction date
Planned sale
Price
33.44
Quantity 3,920 -12.7%
Value US$131,073
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.79
Quantity 1,448 -34.8%
Value US$47,483
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.17
Quantity 4,386 -51.3%
Value US$141,106
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.50
Quantity 9,852 -78.4%
Value US$320,190
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.50
Quantity 150 -5.2%
Value US$4,875
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
32.20
Quantity 263 -8.8%
Value US$8,468
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
31.52
Quantity 3,104 -51.1%
Value US$97,841
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
30.38
Quantity 800 -11.6%
Value US$24,307
5AM Partners III, LLC Large shareholder
Transaction date
Sale
Price
30.04
Quantity 14,814 -23.8%
Value US$445,013
5AM Partners III, LLC Large shareholder
Transaction date
Sale
Price
30.04
Quantity 574,823 -23.8%
Value US$17,267,683
Lockey Claire See Remarks Officer
Transaction date
Planned sale
Price
30.00
Quantity 8,000 -59.3%
Value US$240,000
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
25.00
Quantity 5,000 -40.0%
Value US$125,000
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
25.00
Quantity 15,000 -66.7%
Value US$375,000
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
25.00
Quantity 15,000 -66.7%
Value US$375,000
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
22.50
Quantity 3,334 -55.1%
Value US$75,015
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
20.06
Quantity 2,500 -48.0%
Value US$50,144
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
19.86
Quantity 100 -3.6%
Value US$1,986
VEITINGER KLAUS R DR Non-Executive Director
Transaction date
Planned sale
Price
19.32
Quantity 2,400 -46.0%
Value US$46,357
Berman Lance Chief Medical Officer and SVP Officer
Transaction date
Planned sale
Price
22.00
Quantity 5,000 -40.0%
Value US$110,000
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
25.07
Quantity 49,000 -0.6%
Value US$1,228,430
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-08-18 2016-08-17 B Purchase DONDERO JAMES D Large shareholder
63,431 -43.4%
223.03
US$1,074,364 		63,431 -43.4% 223.03 US$1,074,364
2016-08-18 2016-08-16 S Sale Montgomery Monte

Chief Accounting Officer

Officer
67,186 -36.2%
137.68
US$4,827,835 		67,186 -36.2% 137.68 US$4,827,835
2016-08-15 2016-08-11 S Sale DONDERO JAMES D Large shareholder
51,272 -28.1%
404.67
US$412,302 		51,272 -28.1% 404.67 US$412,302
2016-07-26 2016-07-25 S Sale ORBIMED ADVISORS LLC Large shareholder
343,600 -9.3%
31.98
US$10,988,328 		343,600 -9.3% 31.98 US$10,988,328
2016-07-26 2016-07-22 S Sale ORBIMED ADVISORS LLC Large shareholder
3,700,000 -50.0%
32.00
US$118,400,000 		3,700,000 -50.0% 32.00 US$118,400,000
2016-06-08 2016-06-07 S Sale SPIEGELMAN DANIEL K Non-Executive Director
1,013 -45.0%
19.31
US$19,562 		1,013 -45.0% 19.31 US$19,562
2016-06-08 2016-06-07 S Sale Hillan Kenneth J. Non-Executive Director
1,013 -45.0%
19.31
US$19,563 		1,013 -45.0% 19.31 US$19,563
2016-06-08 2016-06-07 S Sale Butler John P. Non-Executive Director
1,013 -26.2%
19.32
US$19,570 		1,013 -26.2% 19.32 US$19,570
2016-06-08 2016-06-07 S Sale Torley Helen Non-Executive Director
1,013 -45.0%
19.32
US$19,570 		1,013 -45.0% 19.32 US$19,570
2016-06-08 2016-06-07 S Sale HASTINGS PAUL J Non-Executive Director
1,013 -28.9%
19.32
US$19,573 		1,013 -28.9% 19.32 US$19,573
2016-06-08 2016-06-07 S Sale MCGIRR DAVID W J Non-Executive Director
1,013 -27.1%
19.34
US$19,588 		1,013 -27.1% 19.34 US$19,588
2016-03-16 2016-03-16 B Purchase BALL KRISTINE M

Chief Financial Officer & SVP

Officer
7,000 +32.9%
12.15
US$85,050 		7,000 +32.9% 12.15 US$85,050
2016-03-16 2016-03-15 B Purchase Schuetz Thomas J. Non-Executive Director
30,000 +757.2%
13.39
US$401,832 		30,000 +757.2% 13.39 US$401,832
2016-01-04 2015-12-31 PlS Planned sale Stahl Wilhelm

SVP, Chief Technology Officer

Officer
20,000 -57.4%
28.53
US$570,558 		20,000 -57.4% 28.53 US$570,558
2015-12-23 2015-12-23 S Sale ORBIMED ADVISORS LLC Large shareholder
52,058 -0.7%
27.54
US$1,433,677 		52,058 -0.7% 27.54 US$1,433,677
2015-12-23 2015-12-23 S Sale ORBIMED ADVISORS LLC Large shareholder
47,942 -0.6%
26.78
US$1,283,887 		47,942 -0.6% 26.78 US$1,283,887
2015-12-23 2015-12-22 S Sale ORBIMED ADVISORS LLC Large shareholder
38,630 -0.5%
27.02
US$1,043,783 		38,630 -0.5% 27.02 US$1,043,783
2015-12-23 2015-12-22 S Sale ORBIMED ADVISORS LLC Large shareholder
111,370 -1.5%
26.39
US$2,939,054 		111,370 -1.5% 26.39 US$2,939,054
2015-12-23 2015-12-21 S Sale ORBIMED ADVISORS LLC Large shareholder
14,171 -0.2%
28.39
US$402,315 		14,171 -0.2% 28.39 US$402,315
2015-12-23 2015-12-21 S Sale ORBIMED ADVISORS LLC Large shareholder
235,829 -3.0%
27.50
US$6,485,298 		235,829 -3.0% 27.50 US$6,485,298
2015-12-09 2015-12-09 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
750 -3.4%
29.50
US$22,125 		750 -3.4% 29.50 US$22,125
2015-12-09 2015-12-07 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
30,000 -58.5%
29.78
US$893,400 		30,000 -58.5% 29.78 US$893,400
2015-12-09 2015-12-07 PlS Planned sale Orwin John A

President & CEO

Executive Director
800 -1.4%
29.67
US$23,733 		800 -1.4% 29.67 US$23,733
2015-12-09 2015-12-07 PlS Planned sale Orwin John A

President & CEO

Executive Director
7,379 -11.8%
28.52
US$210,451 		7,379 -11.8% 28.52 US$210,451
2015-12-09 2015-12-07 PlS Planned sale Orwin John A

President & CEO

Executive Director
6,821 -9.8%
27.85
US$189,949 		6,821 -9.8% 27.85 US$189,949
2015-12-04 2015-12-04 PlS Planned sale Orwin John A

President & CEO

Executive Director
20,000 -25.2%
25.00
US$500,000 		20,000 -25.2% 25.00 US$500,000
2015-12-04 2015-12-02 PlS Planned sale Orwin John A

President & CEO

Executive Director
20,000 -25.2%
25.00
US$500,000 		20,000 -25.2% 25.00 US$500,000
2015-10-22 2015-10-22 B Purchase ORBIMED ADVISORS LLC Large shareholder
310,700 +4.1%
12.92
US$4,014,244 		310,700 +4.1% 12.92 US$4,014,244
2015-10-22 2015-10-22 B Purchase ORBIMED ADVISORS LLC Large shareholder
189,300 +2.6%
11.97
US$2,265,921 		189,300 +2.6% 11.97 US$2,265,921
2015-08-19 2015-08-17 PlS Planned sale Orwin John A

President & CEO

Executive Director
2,366 -5.3%
25.00
US$59,150 		2,366 -5.3% 25.00 US$59,150
2015-08-03 2015-07-31 PlS Planned sale Orwin John A

President & CEO

Executive Director
200 -0.8%
34.14
US$6,828 		200 -0.8% 34.14 US$6,828
2015-08-03 2015-07-31 PlS Planned sale Orwin John A

President & CEO

Executive Director
9,800 -28.0%
33.51
US$328,397 		9,800 -28.0% 33.51 US$328,397
2015-08-03 2015-07-30 PlS Planned sale Orwin John A

President & CEO

Executive Director
200 -0.7%
34.11
US$6,822 		200 -0.7% 34.11 US$6,822
2015-08-03 2015-07-30 PlS Planned sale Orwin John A

President & CEO

Executive Director
19,800 -39.6%
33.57
US$664,751 		19,800 -39.6% 33.57 US$664,751
2015-06-02 2015-06-01 PlS Planned sale Orwin John A

President & CEO

Executive Director
5,204 -14.8%
36.94
US$192,255 		5,204 -14.8% 36.94 US$192,255
2015-06-02 2015-06-01 PlS Planned sale Orwin John A

President & CEO

Executive Director
8,351 -19.2%
35.79
US$298,893 		8,351 -19.2% 35.79 US$298,893
2015-06-02 2015-05-29 PlS Planned sale Orwin John A

President & CEO

Executive Director
5,306 -13.2%
36.98
US$196,208 		5,306 -13.2% 36.98 US$196,208
2015-06-02 2015-05-29 PlS Planned sale Orwin John A

President & CEO

Executive Director
14,694 -26.7%
36.40
US$534,793 		14,694 -26.7% 36.40 US$534,793
2015-05-20 2015-05-18 S Sale ORBIMED ADVISORS LLC Large shareholder
1,457,551 -16.5%
34.13
US$49,746,216 		1,457,551 -16.5% 34.13 US$49,746,216
2015-05-13 2015-05-11 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
5,834 -68.3%
36.06
US$210,387 		5,834 -68.3% 36.06 US$210,387
2015-04-13 2015-04-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
5,832 -68.3%
35.35
US$206,179 		5,832 -68.3% 35.35 US$206,179
2015-03-12 2015-03-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
5,834 -68.3%
38.67
US$225,594 		5,834 -68.3% 38.67 US$225,594
2015-03-05 2015-03-05 PlS Planned sale BALL KRISTINE M

Chief Financial Officer & SVP

Officer
3,000 -28.6%
41.00
US$123,000 		3,000 -28.6% 41.00 US$123,000
2015-03-06 2015-03-04 PlS Planned sale Lockey Claire

See Remarks

Officer
10,000 -64.5%
40.00
US$400,000 		10,000 -64.5% 40.00 US$400,000
2015-02-27 2015-02-27 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
348 -6.0%
39.00
US$13,572 		348 -6.0% 39.00 US$13,572
2015-02-27 2015-02-26 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
5,000 -46.1%
39.00
US$195,000 		5,000 -46.1% 39.00 US$195,000
2015-02-25 2015-02-24 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
2,300 -23.5%
38.63
US$88,843 		2,300 -23.5% 38.63 US$88,843
2015-02-25 2015-02-24 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
2,700 -21.6%
37.82
US$102,106 		2,700 -21.6% 37.82 US$102,106
2015-02-25 2015-02-24 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
5,000 -24.0%
39.00
US$195,000 		5,000 -24.0% 39.00 US$195,000
2015-02-10 2015-02-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
100 -3.6%
32.74
US$3,274 		100 -3.6% 32.74 US$3,274
2015-02-10 2015-02-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
5,734 -67.1%
32.10
US$184,085 		5,734 -67.1% 32.10 US$184,085
2015-01-23 2015-01-21 PlS Planned sale Lockey Claire

See Remarks

Officer
5,000 -47.6%
35.00
US$175,000 		5,000 -47.6% 35.00 US$175,000
2015-01-23 2015-01-21 PlS Planned sale BALL KRISTINE M

Chief Financial Officer & SVP

Officer
3,000 -28.6%
36.00
US$108,000 		3,000 -28.6% 36.00 US$108,000
2015-01-23 2015-01-21 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
55,000 -68.0%
35.00
US$1,925,000 		55,000 -68.0% 35.00 US$1,925,000
2015-01-16 2015-01-14 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
1,080 -4.0%
34.09
US$36,821 		1,080 -4.0% 34.09 US$36,821
2015-01-16 2015-01-14 PlS Planned sale Krasnow Ronald A.

See Remarks

Officer
3,920 -12.7%
33.44
US$131,073 		3,920 -12.7% 33.44 US$131,073
2015-01-14 2015-01-12 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
1,448 -34.8%
32.79
US$47,483 		1,448 -34.8% 32.79 US$47,483
2015-01-14 2015-01-12 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
4,386 -51.3%
32.17
US$141,106 		4,386 -51.3% 32.17 US$141,106
2014-12-12 2014-12-12 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
9,852 -78.4%
32.50
US$320,190 		9,852 -78.4% 32.50 US$320,190
2014-12-12 2014-12-11 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
150 -5.2%
32.50
US$4,875 		150 -5.2% 32.50 US$4,875
2014-12-12 2014-12-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
263 -8.8%
32.20
US$8,468 		263 -8.8% 32.20 US$8,468
2014-12-12 2014-12-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
3,104 -51.1%
31.52
US$97,841 		3,104 -51.1% 31.52 US$97,841
2014-12-12 2014-12-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
800 -11.6%
30.38
US$24,307 		800 -11.6% 30.38 US$24,307
2014-12-11 2014-12-09 S Sale 5AM Partners III, LLC Large shareholder
14,814 -23.8%
30.04
US$445,013 		14,814 -23.8% 30.04 US$445,013
2014-12-11 2014-12-09 S Sale 5AM Partners III, LLC Large shareholder
574,823 -23.8%
30.04
US$17,267,683 		574,823 -23.8% 30.04 US$17,267,683
2014-12-10 2014-12-09 PlS Planned sale Lockey Claire

See Remarks

Officer
8,000 -59.3%
30.00
US$240,000 		8,000 -59.3% 30.00 US$240,000
2014-12-02 2014-11-28 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
5,000 -40.0%
25.00
US$125,000 		5,000 -40.0% 25.00 US$125,000
2014-11-26 2014-11-25 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
15,000 -66.7%
25.00
US$375,000 		15,000 -66.7% 25.00 US$375,000
2014-11-26 2014-11-24 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
15,000 -66.7%
25.00
US$375,000 		15,000 -66.7% 25.00 US$375,000
2014-11-24 2014-11-20 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
3,334 -55.1%
22.50
US$75,015 		3,334 -55.1% 22.50 US$75,015
2014-11-12 2014-11-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
2,500 -48.0%
20.06
US$50,144 		2,500 -48.0% 20.06 US$50,144
2014-10-15 2014-10-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
100 -3.6%
19.86
US$1,986 		100 -3.6% 19.86 US$1,986
2014-10-15 2014-10-10 PlS Planned sale VEITINGER KLAUS R DR Non-Executive Director
2,400 -46.0%
19.32
US$46,357 		2,400 -46.0% 19.32 US$46,357
2014-09-25 2014-09-24 PlS Planned sale Berman Lance

Chief Medical Officer and SVP

Officer
5,000 -40.0%
22.00
US$110,000 		5,000 -40.0% 22.00 US$110,000
2014-09-18 2014-09-17 S Sale ORBIMED ADVISORS LLC Large shareholder
49,000 -0.6%
25.07
US$1,228,430 		49,000 -0.6% 25.07 US$1,228,430
Explore more

More insider trading research around Relypsa Inc

More insider trades in United States
Insider trading in North America